Weigao Orthopaedic(SH:688161) Xin Lang Cai Jing·2025-11-17 01:27Core Viewpoint - Weigao Orthopedics has shown a positive performance in terms of stock price and trading volume, with significant financing activities indicating strong investor interest [1][2]. Financing Activities - On November 14, Weigao Orthopedics experienced a stock price increase of 1.24%, with a trading volume of 71.93 million yuan. The financing buy-in amount for the day was 14.26 million yuan, while the financing repayment was 12.78 million yuan, resulting in a net financing buy of 1.47 million yuan [1]. - As of November 14, the total financing and securities lending balance for Weigao Orthopedics was 150 million yuan, with the financing balance at 149 million yuan, accounting for 1.20% of the circulating market value, which is above the 90th percentile level over the past year [1]. Shareholder Information - As of September 30, the number of shareholders for Weigao Orthopedics reached 10,700, an increase of 18.33% compared to the previous period. The average circulating shares per person decreased by 15.49% to 37,418 shares [2]. - The company has distributed a total of 575 million yuan in dividends since its A-share listing, with 367 million yuan distributed over the past three years [3]. Financial Performance - For the period from January to September 2025, Weigao Orthopedics reported a revenue of 1.106 billion yuan, reflecting a year-on-year growth of 2.12%. The net profit attributable to the parent company was 207 million yuan, showing a significant increase of 26.24% year-on-year [2]. Institutional Holdings - As of September 30, 2025, Hong Kong Central Clearing Limited was the seventh-largest circulating shareholder, holding 3.4373 million shares, an increase of 392,000 shares from the previous period. Additionally, Penghua Medical Technology Stock A entered as the tenth-largest circulating shareholder with 1.0961 million shares [3].